A new study published online by the New England Journal of Medicine indicates that an intravenous dose of zoledronic acid within 90 days after a hip fracture (and yearly afterward) to reduce the risk of another fracture and death from a fracture. That is tremendous news, since someone who has already suffered such a traumatic experience may not be able to tolerate the upright posture and other requirements demanded by oral bisphosphonate medications. Plus, the study dispels concerns that receiving the infusion too soon after an injury could interfere with healing. Since the FDA recently approved the use of zoledronic acid for the treatment of osteoporosis, this investigation shows the drug could be useful to more people that ever. For more, check out http://www.boston.com/news/nation/articles/2007/09/18/osteoporosis_drug_found_to_cut_risk_of_death_after_broken_hip/.
Published On: September 24, 2007